IPO Trending
DPLSME / BSEListed
Dipna Pharmachem

Incorporated in 2011, Dipna Pharmachem Limited is involved in the trading and distribution of a wide range of pharmaceutical raw materials, including APIs, excipients, and chemical formulation products, and began selling chemicals on a commission basis in 2022. Operating in Ahmedabad and nearby regions, the company offers a portfolio of 61 APIs and intermediates covering categories like cephalosporins, cardiovascular, antibacterial, quinolones, veterinary, antiviral, anti-inflammatory, neuropsychiatry, and steroid hormones. It supplies essential raw materials to pharmaceutical industries, a sector recognized as an essential service by the Government.

₹38 - ₹382.77x sub
Listed Price₹32.00
Listing Gain-15.79%

Subscription Status

2.77xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date25 Aug 2022
Close Date30 Aug 2022
Listing Date08 Sep 2022
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Dipna Pharmachem IPO Subscription Demand

Live subscription status and bidding analysis for Dipna Pharmachem (DPL) IPO. The issue is subscribed 2.77x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions